Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 8/20 | 0.40 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.40 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.40 |
| ▸ | ERN1 | O75460 | 2/20 | 0.39 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.38 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.37 |
| ▸ | TGM2 | P21980 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28852389 | 0.98 | DDAH1 (0.39) | ACHEDDAH1MAPTCACNA1BAPBA1 | |
| SCHEMBL1276392 | 0.95 | DDAH1 (0.46) | ACHEDDAH1MAPTCACNA1BAPBA1 | |
| SCHEMBL20207166 | 0.93 | PAOX (0.47) | ACHEDDAH1MAPTCACNA1BAPBA1 | |
| Hydrochloric Acid SCHEMBL28713623 | 0.93 | DDAH1 (0.45) | ACHEDDAH1MAPTCACNA1BAPBA1 | |
| SCHEMBL6951293 | 0.93 | PAOX (0.47) | ACHEDDAH1MAPTCACNA1BAPBA1 | |
| Hydrochloric Acid SCHEMBL2525927 | 0.91 | PAOX (0.46) | ACHEDDAH1ERN1PAOXTGM2 | |
| Trifluoroacetic Acid SCHEMBL1276786 | 0.89 | HDAC6 (0.36) | ACHEDDAH1MAPTCACNA1BAPBA1 | |
| SCHEMBL7001155 | 0.89 | MAPT (0.42) | ACHEMAPTCACNA1BAPBA1ERN1 | |
| Hydrochloric Acid SCHEMBL2528348 | 0.87 | MAPT (0.41) | ACHEMAPTCACNA1BAPBA1ERN1 | |
| SCHEMBL3676772 | 0.86 | TGM2 (0.46) | ACHEERN1TGM2EPHX2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108719645-B | Creep feed mate | 宁波科瑞特动物药业有限公司 | 2021-08-06 | — | — | CN | claimed |
| CN-108719645-A | A kind of effective novel creep feed companion | 宁波科瑞特动物药业有限公司 | 2018-11-02 | — | — | CN | claimed |
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2025-09-25 | — | — | US | disclosed |
| CN-108719645-B | Creep feed mate | 宁波科瑞特动物药业有限公司 | 2021-08-06 | — | — | CN | disclosed |
| CN-108719645-A | A kind of effective novel creep feed companion | 宁波科瑞特动物药业有限公司 | 2018-11-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | ACHE 4590/4885DDAH1 655/4885MAPT 2072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.